NCI OPERATIONAL TASK ORDERCOVID-19: INITIATE DCEG COVID-19 CASE STUDY: YT 20-144. PID # 600.129.20.01.018.001.0005COVID-19: INITIATE DCEG COVID-19

弗雷德里克国家癌症研究实验室（FNLCR）是一个政府拥有的承包商运营（GOCO），联邦资助的研究和开发中心 （FFRDC），由美国国立卫生研究院（NIH）通过国家癌症研究所赞助，并根据联邦采购条例（FAR）35.017建立。 FNLCR的目的是提供一个独特的生物医学资源，用于开发新技术，并将基础科学发现转化为预防，诊断和治疗癌症，人类免疫缺陷病毒（HIV）/获得性免疫缺陷综合征（AIDS）和其他疾病的新制剂。 作为一个FFRDC，FNLCR可以接触国家癌症研究所，包括接触政府和非政府的敏感和专有信息，远远超出了正常合同关系范围内的接触。这种接触便利了国家癌症研究所规划、执行、评估和调整政策、方案和项目，以满足国家的需要。因此，承包商必须确保公众利益始终高于任何公司利益，并及时发现和缓解潜在或实际的组织利益冲突。承包商必须确保在所有技术、研究、政策和市场问题上的客观性和独立性。 作为承包商管理实验室工作的一部分，承包商应与更广泛的研究界保持关系，以增强实验室的智力活力和研究相关性，并通过伙伴关系提供与FNLCR使命需求相关的最佳能力。承包者应积极发展和寻求与公共和私人合作伙伴的合作，以满足生物医学研究的迫切要求，实现发现、创新和全面改善人类健康的目标。 承包商将以多种方式与民间、学术和私人组织合作，推进生物医学研究、科学发现和FNLCR的使命。

The Frederick National Laboratory for Cancer Research (FNLCR) is a Government-Owned Contractor-Operated (GOCO), Federally Funded Research and Development Center (FFRDC), sponsored by the National Institutes of Health (NIH) through the National Cancer Institute, and established in accordance with Federal Acquisition Regulation (FAR) 35.017. The purpose of the FNLCR is to provide a unique biomedical resource for the development of new technologies and the translation of basic science discoveries into novel agents for the prevention, diagnosis, and treatment of cancer, Human Immunodeficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS), and other diseases. As a FFRDC, the FNLCR has access to the National Cancer Institute (NCI), including access to Governmental and Non-Governmental sensitive and proprietary information, well beyond that which is encountered within the boundaries of a normal contractual relationship. This access facilitates the NCI in the planning, executing, assessing, and redirecting the policies, programs, and projects as necessary to meet the nation’s needs. Accordingly, the Contractor must ensure that the public’s interest is always placed above any corporate interest, and potential or actual organizational conflicts of interest are promptly identified and mitigated. The Contractor must ensure objectivity and independence in all technology, research, policy, and market matters. As part of the Contractor’s stewardship of the laboratory, it is expected that the Contractor maintain relationships with the broader research community to enhance the intellectual vitality and research relevance of the laboratory, and to bring the best possible capabilities forward as it pertains to the FNLCR mission needs through partnerships. The Contractor shall actively develop and pursue collaborative engagement with public and private partners, to address urgent requirements in biomedical research towards the goals of discovery, innovation and the overall improvement of human health. The Contractor is to work with civic, academic and private organizations in multiple ways to advance biomedical research, scientific discovery, and the mission of the FNLCR.